Colgate-Palmolive (NYSE:CL) Shares Sold by Pacifica Partners Inc.

Pacifica Partners Inc. reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 97.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,020 shares of the company’s stock after selling 35,874 shares during the quarter. Pacifica Partners Inc.’s holdings in Colgate-Palmolive were worth $92,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive during the third quarter valued at approximately $42,000. Capital Performance Advisors LLP acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $64,000. True Wealth Design LLC lifted its stake in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after purchasing an additional 672 shares during the period. Finally, Continuum Advisory LLC boosted its holdings in Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $87.73 on Wednesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The business’s 50 day moving average price is $92.36 and its 200 day moving average price is $97.92. The company has a market cap of $71.68 billion, a price-to-earnings ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of recent analyst reports. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $103.63.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.